Accurate Wealth Management LLC decreased its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 35.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,746 shares of the technology company’s stock after selling 5,385 shares during the quarter. Accurate Wealth Management LLC’s holdings in AMETEK were worth $2,053,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of AME. Norges Bank bought a new position in AMETEK during the second quarter valued at approximately $650,613,000. Amundi increased its stake in AMETEK by 266.1% in the 2nd quarter. Amundi now owns 1,512,966 shares of the technology company’s stock worth $275,345,000 after acquiring an additional 1,099,748 shares during the last quarter. Invesco Ltd. raised its holdings in shares of AMETEK by 22.3% during the 2nd quarter. Invesco Ltd. now owns 4,254,475 shares of the technology company’s stock worth $769,890,000 after acquiring an additional 775,078 shares in the last quarter. Nordea Investment Management AB raised its holdings in shares of AMETEK by 825.0% during the 4th quarter. Nordea Investment Management AB now owns 852,585 shares of the technology company’s stock worth $176,153,000 after acquiring an additional 760,410 shares in the last quarter. Finally, Lazard Asset Management LLC boosted its position in shares of AMETEK by 35.7% during the 3rd quarter. Lazard Asset Management LLC now owns 2,645,977 shares of the technology company’s stock valued at $497,444,000 after acquiring an additional 695,419 shares during the last quarter. 87.43% of the stock is currently owned by institutional investors.
Insider Buying and Selling at AMETEK
In other news, Director Thomas A. Amato sold 530 shares of the firm’s stock in a transaction that occurred on Tuesday, March 24th. The shares were sold at an average price of $216.78, for a total transaction of $114,893.40. Following the transaction, the director directly owned 4,480 shares of the company’s stock, valued at approximately $971,174.40. This trade represents a 10.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.54% of the company’s stock.
AMETEK Stock Down 1.1%
AMETEK (NYSE:AME – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The technology company reported $2.01 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.07. AMETEK had a return on equity of 16.55% and a net margin of 20.00%.The business had revenue of $2 billion for the quarter, compared to analysts’ expectations of $1.94 billion. During the same quarter in the prior year, the business earned $1.87 EPS. The firm’s revenue for the quarter was up 13.4% on a year-over-year basis. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. Sell-side analysts predict that AMETEK, Inc. will post 7.15 EPS for the current year.
AMETEK Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Monday, March 16th will be issued a dividend of $0.34 per share. This is an increase from AMETEK’s previous quarterly dividend of $0.31. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, March 16th. AMETEK’s payout ratio is 21.25%.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on AME shares. BMO Capital Markets started coverage on shares of AMETEK in a research note on Friday. They set an “outperform” rating and a $253.00 price target on the stock. DA Davidson reissued a “buy” rating and issued a $240.00 price objective on shares of AMETEK in a research note on Wednesday, February 4th. Morgan Stanley upped their target price on shares of AMETEK from $215.00 to $235.00 and gave the company an “equal weight” rating in a research report on Thursday, March 12th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $257.00 price target on shares of AMETEK in a report on Wednesday, February 4th. Finally, KeyCorp lifted their price target on AMETEK from $235.00 to $260.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, AMETEK currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.50.
AMETEK Profile
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
Recommended Stories
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
